StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
147
This month
2
This week
1
This year
11
Publishing Date
2024 - 01 - 02
3
2023 - 12 - 28
3
2023 - 12 - 26
2
2023 - 12 - 14
2
2023 - 12 - 06
2
2023 - 12 - 01
2
2023 - 11 - 30
3
2023 - 11 - 27
2
2023 - 11 - 26
2
2023 - 11 - 22
2
2023 - 11 - 17
3
2023 - 11 - 14
2
2023 - 11 - 11
2
2023 - 09 - 21
2
2023 - 08 - 01
2
2023 - 02 - 07
2
2023 - 01 - 09
2
2022 - 12 - 23
2
2022 - 02 - 14
1
2022 - 02 - 10
1
2022 - 02 - 08
1
2022 - 01 - 25
1
2022 - 01 - 19
1
2022 - 01 - 04
1
2021 - 12 - 22
1
2021 - 12 - 15
1
2021 - 12 - 09
2
2021 - 11 - 24
1
2021 - 11 - 23
1
2021 - 11 - 13
1
2021 - 11 - 03
2
2021 - 10 - 12
1
2021 - 10 - 07
1
2021 - 10 - 05
2
2021 - 09 - 28
1
2021 - 09 - 21
2
2021 - 09 - 13
1
2021 - 09 - 08
1
2021 - 08 - 13
1
2021 - 08 - 11
1
2021 - 08 - 03
1
2021 - 07 - 07
1
2021 - 06 - 14
1
2021 - 06 - 08
1
2021 - 05 - 27
1
2021 - 05 - 14
1
2021 - 05 - 12
1
2021 - 03 - 31
1
2021 - 03 - 04
1
2021 - 02 - 17
1
2021 - 02 - 16
1
2021 - 02 - 11
2
2021 - 02 - 04
1
2021 - 02 - 02
1
2021 - 01 - 29
1
2021 - 01 - 28
1
2021 - 01 - 12
1
2021 - 01 - 05
1
2020 - 12 - 23
1
2020 - 12 - 01
1
Sector
Communications
1
Consumer durables
1
Electronic technology
2
Finance
7
Health technology
147
Manufacturing
1
Mining, quarrying, and oil and gas extraction
1
N/a
10
Process industries
1
Producer manufacturing
7
Professional, scientific, and technical services
2
Retail trade
1
Technology services
5
Tags
Active
1
Aesthetic
1
Agreement
3
Application
6
Authorization
1
Beauty
1
Biopharma
2
Bla submission
1
Cel
1
Ceo
2
Chmp
1
Clinical-trials-phase-iii
1
Commercial
2
Commercialization
3
Companies
3
Company
1
Conference
22
Corporation
5
Day
2
Deadline
15
Deal
2
Direct
1
Dmd
1
Drug
3
Earnings
1
Energy
1
Europe
1
Ev
1
Events
4
Eye
3
Fda
7
Financial
6
Financial results
5
First
2
Food
2
Global
9
Health
2
Ipo
3
License
5
Macular
2
Market
3
Medical
2
Meeting
2
Million
3
N/a
128
Nasdaq
2
Offering
5
Ons-5010
13
Pharm-country
9
Phase 3
5
Positive
6
Presentation
3
Results
12
Retina
11
Submission
3
Therapeutics
71
Treatment
9
Trial
7
Update
6
Year
8
Entities
Abbvie inc.
156
Abeona therapeutics inc.
116
Adc therapeutics sa
145
Addex therapeutics ltd
101
Akebia therapeutics, inc.
117
Akero therapeutics, inc.
104
Aldeyra therapeutics, inc.
123
Allogene therapeutics, inc.
177
Alphabet inc.
197
Alterity therapeutics limited
106
Amarin corporation plc
138
Amgen inc.
137
Aquestive therapeutics, inc.
147
Astrazeneca plc
118
Autolus therapeutics plc
105
Axsome therapeutics, inc.
116
Biogen inc.
104
Bioxcel therapeutics, inc.
168
Brainstorm cell therapeutics inc.
131
Bristol-myers squibb company
131
Calliditas therapeutics ab
142
Denali therapeutics inc.
104
Eli lilly and company
284
Fate therapeutics, inc.
256
Fulcrum therapeutics, inc.
134
G1 therapeutics, inc.
136
Gilead sciences, inc.
107
Glaxosmithkline plc
151
Horizon therapeutics public limited company
146
Hoth therapeutics, inc.
109
Intellia therapeutics, inc.
112
Johnson & johnson
528
Karyopharm therapeutics inc.
166
Lineage cell therapeutics, inc.
109
Medicenna therapeutics corp.
108
Morgan stanley
208
Morphosys ag
190
Nektar therapeutics
370
Novartis ag
226
Nurix therapeutics, inc.
147
Oncocyte corporation
182
Onconova therapeutics, inc.
114
Outlook therapeutics, inc.
147
Plus therapeutics, inc.
124
Poseida therapeutics, inc.
110
Ptc therapeutics, inc.
270
Relief therapeutics holding sa
109
Sanofi
711
Sarepta therapeutics, inc.
164
Seres therapeutics, inc.
116
Sorrento therapeutics, inc.
229
Spero therapeutics, inc.
121
Tg therapeutics, inc.
148
Therapeuticsmd, inc.
194
Travere therapeutics inc.
122
United therapeutics corporation
142
Vaxart, inc.
185
Vistagen therapeutics, inc.
116
Vyne therapeutics inc.
172
Y-mabs therapeutics, inc.
178
Symbols
ADVM
1
AGTC
1
AHCO
7
ALPMF
1
ALPMY
1
ANNX
1
APLS
1
BCLI
3
BIIB
1
CGRNQ
3
CLSD
1
DCGO
1
DG
1
DMTK
2
EGRX
3
EH
2
EYPT
1
FMC
1
FTCH
1
ILMN
2
INSE
1
IONS
1
IOT
1
JNJ
1
KOD
3
KVUE
6
LICY
2
LUMN
1
MASI
1
MEDE
1
MVST
1
OCUL
1
OCUP
1
OPT
3
ORGN
1
OTLK
147
PAYC
1
REGN
1
SCYX
6
SEDG
6
SKIN
2
SLRN
4
SPWR
1
VSAT
2
XPEL
1
Exchanges
Nasdaq
147
Nyse
8
Crawled Date
2024 - 01 - 02
3
2023 - 12 - 28
2
2023 - 12 - 26
2
2023 - 12 - 14
2
2023 - 12 - 06
2
2023 - 12 - 04
2
2023 - 12 - 01
2
2023 - 11 - 30
3
2023 - 11 - 27
3
2023 - 11 - 22
2
2023 - 11 - 17
3
2023 - 11 - 14
2
2023 - 11 - 11
2
2023 - 09 - 21
2
2023 - 08 - 01
2
2023 - 02 - 07
2
2023 - 01 - 09
2
2022 - 12 - 23
2
2022 - 02 - 14
1
2022 - 02 - 10
1
2022 - 02 - 08
1
2022 - 01 - 25
1
2022 - 01 - 19
1
2022 - 01 - 04
1
2021 - 12 - 22
1
2021 - 12 - 15
1
2021 - 12 - 09
2
2021 - 11 - 24
1
2021 - 11 - 23
1
2021 - 11 - 13
1
2021 - 11 - 03
2
2021 - 10 - 12
1
2021 - 10 - 07
1
2021 - 10 - 05
2
2021 - 09 - 28
1
2021 - 09 - 21
2
2021 - 09 - 13
1
2021 - 09 - 08
1
2021 - 08 - 13
1
2021 - 08 - 11
1
2021 - 08 - 03
1
2021 - 07 - 07
1
2021 - 06 - 14
1
2021 - 06 - 08
1
2021 - 05 - 27
1
2021 - 05 - 14
1
2021 - 05 - 12
1
2021 - 03 - 31
1
2021 - 03 - 04
1
2021 - 02 - 17
1
2021 - 02 - 16
1
2021 - 02 - 11
2
2021 - 02 - 04
1
2021 - 02 - 02
1
2021 - 01 - 29
1
2021 - 01 - 28
1
2021 - 01 - 12
1
2021 - 01 - 05
1
2020 - 12 - 23
1
2020 - 12 - 01
1
Crawled Time
00:00
4
02:00
1
04:00
1
04:20
2
05:01
1
10:00
1
11:00
1
12:00
7
12:15
14
12:20
18
12:30
1
13:00
15
13:03
1
13:15
2
13:20
8
13:30
9
14:00
5
14:01
1
14:05
1
14:20
2
14:30
6
15:00
4
16:00
8
16:20
1
17:00
4
18:00
4
19:00
1
20:00
5
20:20
3
21:00
9
22:00
4
23:00
3
Source
www.biospace.com
19
www.globenewswire.com
86
www.prnewswire.com
42
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
entities :
Outlook therapeutics, inc.
save search
Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsight
Published:
2024-04-22
(Crawled : 22:00)
- prnewswire.com
JNJ
|
News
|
$149.56
0.3%
-0.17%
6.9M
|
Health Technology
|
0.89%
|
O:
0.89%
H:
0.0%
C:
0.0%
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1.36%
|
O:
1.48%
H:
2.8%
C:
-0.12%
OPT
|
News
|
$3.36
-0.59%
2.37%
2K
|
Health Technology
|
-0.59%
|
O:
3.25%
H:
0.0%
C:
-3.72%
OCUL
|
News
|
$5.0
-1.48%
-1.5%
2.3M
|
Health Technology
|
-1.57%
|
O:
0.79%
H:
0.59%
C:
-2.34%
KOD
|
News
|
$3.33
-2.63%
-2.7%
330K
|
Health Technology
|
-2.63%
|
O:
0.29%
H:
3.79%
C:
-2.92%
EYPT
|
News
|
$17.57
3.66%
3.5%
860K
|
Health Technology
|
3.66%
|
O:
7.73%
H:
2.3%
C:
-3.78%
CLSD
|
News
P
|
$1.37
-2.84%
-3.68%
230K
|
Health Technology
|
-2.84%
|
O:
1.42%
H:
3.5%
C:
-4.2%
ADVM
|
News
|
$11.0
-3.0%
-3.47%
310K
|
Health Technology
|
-3.0%
|
O:
-0.26%
H:
4.95%
C:
-2.74%
macular
growth
market
Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million
Published:
2024-04-15
(Crawled : 20:00)
- globenewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
-4.87%
|
O:
-0.93%
H:
5.85%
C:
2.46%
therapeutics
million
Outlook Therapeutics® Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD
Published:
2024-03-22
(Crawled : 12:00)
- globenewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
16.48%
|
O:
52.98%
H:
8.82%
C:
-19.87%
ons-5010
therapeutics
chmp
positive
treatment
Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million
Published:
2024-03-18
(Crawled : 21:00)
- globenewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
5.33%
|
O:
-2.5%
H:
1.71%
C:
-2.44%
therapeutics
million
Outlook Therapeutics® Announces Effective Date for 1-for-20 Reverse Stock Split
Published:
2024-03-12
(Crawled : 12:00)
- globenewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1997.72%
|
O:
1793.07%
H:
3.89%
C:
-5.51%
therapeutics
Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2024 and Provides Corporate Update
Published:
2024-02-14
(Crawled : 13:00)
- globenewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1950.0%
|
O:
4.47%
H:
5.29%
C:
0.57%
therapeutics
first
year
update
financial
results
Outlook Therapeutics® Doses First Subject in NORSE EIGHT
Published:
2024-01-31
(Crawled : 13:00)
- globenewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1875.9%
|
O:
3.08%
H:
0.0%
C:
-9.77%
therapeutics
first
Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010
Published:
2024-01-23
(Crawled : 13:00)
- globenewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
2311.76%
|
O:
20.59%
H:
11.24%
C:
8.24%
ons-5010
therapeutics
day
fda
million
agreement
ROSEN, LEADING TRIAL ATTORNEYS, Encourages NuScale Power Corporation Investors with Losses to Secure Counsel Before Important January 16 Deadline in Securities Class Action - SMR
Published:
2024-01-02
(Crawled : 21:00)
- prnewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1985.98%
|
O:
-0.25%
H:
8.21%
C:
6.35%
EH
|
$17.35
2.06%
1.82%
810K
|
Technology Services
|
9.81%
|
O:
-1.27%
H:
0.45%
C:
-0.45%
corporation
deadline
trial
OTLK FINAL DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action - OTLK
Published:
2024-01-02
(Crawled : 20:00)
- prnewswire.com
SLRN
|
$4.6
-4.56%
-4.78%
2M
|
|
-42.07%
|
O:
1.51%
H:
1.12%
C:
-5.09%
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1985.98%
|
O:
-0.25%
H:
8.21%
C:
6.35%
EH
|
$17.35
2.06%
1.82%
810K
|
Technology Services
|
9.81%
|
O:
-1.27%
H:
0.45%
C:
-0.45%
deadline
RBLX Investors Have Opportunity to Lead Roblox Corporation Securities Fraud Lawsuit
Published:
2024-01-02
(Crawled : 17:00)
- prnewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1981.22%
|
O:
2.39%
H:
6.12%
C:
-2.55%
corporation
ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acelyrin, Inc. of Class Action Lawsuit and Upcoming Deadline - SLRN
Published:
2023-12-28
(Crawled : 00:00)
- prnewswire.com
SLRN
|
$4.6
-4.56%
-4.78%
2M
|
|
-39.67%
|
O:
0.2%
H:
0.0%
C:
-2.36%
SEDG
4
|
$56.77
4.15%
2.94%
2.4M
|
Producer Manufacturing
|
-41.31%
|
O:
-0.23%
H:
0.66%
C:
-3.02%
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1821.72%
|
O:
5.16%
H:
3.25%
C:
-12.19%
deadline
OTLK Investors Have Opportunity to Lead Outlook Therapeutics, Inc. Securities Fraud Lawsuit
Published:
2023-12-28
(Crawled : 18:00)
- prnewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1821.72%
|
O:
5.16%
H:
3.25%
C:
-12.19%
OUTLOOK INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Outlook To Contact Him Directly To Discuss Their Options
Published:
2023-12-28
(Crawled : 14:00)
- prnewswire.com
FMC
A
|
$58.65
0.69%
0.72%
1.6M
|
Process Industries
|
-7.83%
|
O:
0.08%
H:
0.0%
C:
-0.58%
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1672.59%
|
O:
1.38%
H:
0.0%
C:
-9.02%
EGRX
|
$4.77
4.84%
4.81%
88K
|
Health Technology
|
-8.09%
|
O:
0.96%
H:
4.58%
C:
3.34%
deadline
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN
Published:
2023-12-26
(Crawled : 19:00)
- prnewswire.com
LICY
|
$0.7121
-1.68%
1.17%
1.6M
|
|
12.22%
|
O:
1.22%
H:
4.4%
C:
0.73%
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1738.57%
|
O:
12.11%
H:
0.0%
C:
-7.48%
ILMN
|
$124.46
3.5%
3.34%
1.1M
|
Health Technology
|
-11.5%
|
O:
0.62%
H:
0.88%
C:
0.72%
deadline
trial
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Outlook Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important January 2 Deadline in Securities Class Action - OTLK
Published:
2023-12-26
(Crawled : 18:00)
- prnewswire.com
LICY
|
$0.7121
-1.68%
1.17%
1.6M
|
|
18.41%
|
O:
3.4%
H:
7.89%
C:
2.05%
SCYX
|
$1.55
7.64%
5.88%
150K
|
Health Technology
|
-16.67%
|
O:
1.08%
H:
3.27%
C:
1.6%
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1838.08%
|
O:
1.63%
H:
4.65%
C:
3.72%
deadline
Outlook Therapeutics® Reports Financial Results for Fiscal Year 2023 and Reiterates ONS-5010 Clinical and Regulatory Path Forward in the U.S. and EU
Published:
2023-12-22
(Crawled : 13:00)
- globenewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1816.34%
|
O:
2.71%
H:
3.3%
C:
-3.73%
ons-5010
therapeutics
year
financial
results
OTLK Investors Have Opportunity to Lead Outlook Therapeutics, Inc. Securities Fraud Lawsuit
Published:
2023-12-20
(Crawled : 16:00)
- prnewswire.com
SCYX
|
$1.55
7.64%
5.88%
150K
|
Health Technology
|
-18.42%
|
O:
0.0%
H:
0.26%
C:
-2.63%
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
1882.11%
|
O:
-3.29%
H:
16.47%
C:
4.67%
BCLI
A
|
$0.525
-2.8%
-1.71%
160K
|
Health Technology
|
161.08%
|
O:
-1.48%
H:
4.0%
C:
-2.95%
Outlook Therapeutics® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010
Published:
2023-12-19
(Crawled : 13:00)
- globenewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
2075.07%
|
O:
-1.86%
H:
12.16%
C:
11.81%
ons-5010
therapeutics
fda
study
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Published:
2023-12-17
(Crawled : 20:20)
- prnewswire.com
OTLK
|
News
P
|
$8.2
1.36%
1.34%
150K
|
Health Technology
|
2037.09%
|
O:
0.65%
H:
5.52%
C:
-2.38%
AHCO
|
$9.81
2.19%
1.94%
970K
|
Finance
|
26.74%
|
O:
1.16%
H:
3.07%
C:
-1.53%
deadline
global
← Previous
1
2
3
4
5
6
7
8
Next →
Gainers vs Losers
77%
23%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
26M
|
AGBA
|
$2.97
137.6%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.59
75.27%
41.8%
2M
|
ZAPP
|
$4.44
50.2%
33.12%
370K
|
n/a
MTC
|
$2.24
43.59%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.15
40.0%
29.13%
12M
|
Finance
SHIM
|
$3.045
35.33%
26.23%
870K
|
HKIT
|
$1.33
30.39%
24.16%
390K
|
Technology Services
ABVC
|
$1.35
29.81%
23.53%
7.1M
|
Wholesale Trade
OST
|
$0.5
25.0%
21.88%
280K
|
Your saved searches
Save your searches and get alerts when important news are released.